DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 016267
NDA 016267 describes DESFERAL, which is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. Additional details are available on the DESFERAL profile page.
The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Summary for 016267
| Tradename: | DESFERAL |
| Applicant: | Novartis |
| Ingredient: | deferoxamine mesylate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 016267
| Mechanism of Action | Iron Chelating Activity |
Medical Subject Heading (MeSH) Categories for 016267
Suppliers and Packaging for NDA: 016267
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DESFERAL | deferoxamine mesylate | INJECTABLE;INJECTION | 016267 | NDA | Novartis Pharmaceuticals Corporation | 0078-0467 | 0078-0467-91 | 4 VIAL in 1 CARTON (0078-0467-91) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/VIAL | ||||
| Approval Date: | May 25, 2000 | TE: | AP | RLD: | Yes | ||||
Expired US Patents for NDA 016267
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | DESFERAL | deferoxamine mesylate | INJECTABLE;INJECTION | 016267-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
